These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy. Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323 [TBL] [Abstract][Full Text] [Related]
8. Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting. Kao YH; Steinberg JD; Tay YS; Lim GK; Yan J; Townsend DW; Takano A; Burgmans MC; Irani FG; Teo TK; Yeow TN; Gogna A; Lo RH; Tay KH; Tan BS; Chow PKh; Satchithanantham S; Tan AE; Ng DC; Goh AS EJNMMI Res; 2013 Jul; 3(1):56. PubMed ID: 23883566 [TBL] [Abstract][Full Text] [Related]
9. Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization. Kao YH; Magsombol BM; Toh Y; Tay KH; Chow PKh; Goh AS; Ng DC EJNMMI Res; 2014; 4():33. PubMed ID: 25024931 [TBL] [Abstract][Full Text] [Related]
10. 90Y PET-based dosimetry after selective internal radiotherapy treatments. D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156 [TBL] [Abstract][Full Text] [Related]
11. 3D inpatient dose reconstruction from the PET-CT imaging of 90Y microspheres for metastatic cancer to the liver: feasibility study. Fourkal E; Veltchev I; Lin M; Koren S; Meyer J; Doss M; Yu JQ Med Phys; 2013 Aug; 40(8):081702. PubMed ID: 23927299 [TBL] [Abstract][Full Text] [Related]
12. Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry. d'Abadie P; Walrand S; Hesse M; Annet L; Borbath I; Van den Eynde M; Lhommel R; Jamar F Nucl Med Commun; 2021 Jul; 42(7):747-754. PubMed ID: 33741864 [TBL] [Abstract][Full Text] [Related]
13. Planning dosimetry for Thomas MA; Mahvash A; Abdelsalam M; Kaseb AO; Kappadath SC Med Phys; 2020 Oct; 47(10):5333-5342. PubMed ID: 32790882 [TBL] [Abstract][Full Text] [Related]
14. Retrospective Voxel-Based Dosimetry for Assessing the Ability of the Body-Surface-Area Model to Predict Delivered Dose and Radioembolization Outcome. Kafrouni M; Allimant C; Fourcade M; Vauclin S; Delicque J; Ilonca AD; Guiu B; Manna F; Molinari N; Mariano-Goulart D; Ben Bouallègue F J Nucl Med; 2018 Aug; 59(8):1289-1295. PubMed ID: 29545380 [TBL] [Abstract][Full Text] [Related]
15. For Hepatocellular Carcinoma Treated with Yttrium-90 Microspheres, Dose Volumetrics on Post-Treatment Bremsstrahlung SPECT/CT Predict Clinical Outcomes. Taswell CS; Studenski M; Pennix T; Stover B; Georgiou M; Venkat S; Jones P; Zikria J; Thornton L; Yechieli R; Mohan P; Portelance L; Spieler B Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765603 [TBL] [Abstract][Full Text] [Related]
16. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. Garin E; Lenoir L; Rolland Y; Edeline J; Mesbah H; Laffont S; Porée P; Clément B; Raoul JL; Boucher E J Nucl Med; 2012 Feb; 53(2):255-63. PubMed ID: 22302962 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of voxel-based dosimetry map for predicting response to trans-arterial radioembolization therapy for hepatocellular carcinoma: a pilot study. Yoo MY; Paeng JC; Kim HC; Lee MS; Lee JS; Lee DS; Kang KW; Cheon GJ Nucl Med Commun; 2021 Dec; 42(12):1396-1403. PubMed ID: 34392298 [TBL] [Abstract][Full Text] [Related]